8-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

__________________

FORM 8-K/A

CURRENT REPORT

(Amendment No. 1)

Pursuant To Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): October 11, 2005

E-Z-EM, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

1-11479	11-1999504
(Commission File Number)	(IRS Employer Identification No.)

1111 Marcus Avenue, Lake Success, New York	11042
(Address of Principal Executive Offices)	(Zip Code)

(516) 333-8230

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Explanatory Note

On October 11, 2005, E-Z-EM, Inc. ("E-Z-EM") issued a press release announcing its financial results for the quarter ended September 3, 2005. The press release was filed as an exhibit to, and incorporated by reference into, a Current Report on Form 8-K filed by E-Z-EM on that date. This amendment on Form 8-K/A is being filed to correct an error in the press release issued on October 11, 2005.

Item 2.02 Results of Operations and Financial Condition

Item 7.01 Regulation FD Disclosure

The following information is furnished pursuant to Item 2.02 and Item 7.01:

On October 18, 2005, E-Z-EM issued a press release (the "Correcting Release") correcting certain information included in a press release issued on October 11, 2005, announcing its financial results for the quarter ended September 3, 2005. A copy of the Correcting Release is attached hereto and is incorporated herein by reference in its entirety.

2

Item 9.01 Financial Statements and Exhibits

99.1 Press release issued by E-Z-EM, Inc. on October 11, 2005 (previously filed as an exhibit to the Current Report on Form 8-K filed by E-Z-EM, Inc. on October 11, 2005).

99.2 Press release issued by E-Z-EM, Inc. on October 18, 2005.

3

SIGNATURES:

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 18, 2005 E-Z-EM, Inc.

(Registrant)

By: /s/ Joseph A. Cacchioli                

Joseph A. Cacchioli

Vice President - Controller

4

EXHIBIT INDEX

No. Description

99.1 Press release issued by E-Z-EM, Inc. on October 11, 2005 (previously filed as an exhibit to the Current Report on Form 8-K filed by E-Z-EM, Inc. on October 11, 2005).

99.2 Press Release issued by E-Z-EM, Inc. on October 18, 2005.

5

EX-99.2

Exhibit 99.2

Company Contact:	Investor Relations Contacts:
E-Z-EM, Inc.	Lippert/Heilshorn & Associates, Inc.
Tom Johnson x3317	Kim Sutton Golodetz (kgolodetz@lhai.com)
(800) 544-4624	(212) 838-3777
www.ezem.com	Bruce Voss (bvoss@lhai.com)
	(310) 691-7100
	www.lhai.com

FOR IMMEDIATE RELEASE

E-Z-EM CORRECTS STATEMENT IN

FIRST QUARTER RESULTS PRESS RELEASE

LAKE SUCCESS, N.Y. (October 18, 2005) – E-Z-EM, Inc. (NASDAQ: EZEM) today issued a correction to an error that appeared in the Company’s first quarter fiscal 2006 press release dated October 11, 2005.

In the third paragraph of the commentary section of the press release, the following statement about Reactive Skin Decontamination Lotion “Assuming the Department of Defense successfully completes its FIELD TESTING (emphasis added) of the product IN (emphasis added) the U.S. government’s fiscal 2007” should have read “...the Department of Defense completes its FIELDING PLAN for the product FOR the U.S. government’s fiscal 2007.”

Management regrets any confusion caused by this error.

About E-Z-EM, Inc.

E-Z-EM is a leading manufacturer of contrast agents for gastrointestinal radiology. The Company recently introduced VoLumen® the next generation low density barium sulfate suspension for use as an oral contrast in Multidetector CT (MDCT) and Positron Emission Tomography (PET/CT) studies. The Company also offers Empower®—the only family of CT injectors on the market with patented EDA™ technology that can help detect contrast extravasation—and offers a complete product set for the virtual colonoscopy practitioner. This product line consists of virtual colonoscopy hardware, software, nutritional prep kits and bowel cleaners, tagging agents and a carbon dioxide colon insufflation system. The Company is also the exclusive global manufacturer and marketer of Reactive Skin Decontamination Lotion (RSDL) for first-responder organizations and military services in many countries. RSDL is a liquid skin decontaminant that breaks down chemical agents such as Sarin or VX in seconds, leaving a non-toxic liquid that can be washed away with water.

The statements made in this document contain certain forward-looking statements. Words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates” or variations of such words and similar expressions, are intended to identify such forward-looking statements. The forward-looking statements contained in this release may involve numerous risks and uncertainties, known and unknown, beyond the Company’s control. Such risks and uncertainties include: the ability of the Company to develop its products, successful completion of DoD field testing, and placement of DoD order for RSDL, general military and first-responder market acceptance and sales of RSDL, market acceptance and sales of VoLumen®; future actions by the FDA or other regulatory agencies, overall economic conditions, general market conditions, price increases of raw materials and components, foreign currency exchange rate fluctuations as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc., including but not limited to its Annual Report on Form 10-K for the fiscal year ended May 28, 2005. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements, and investors are cautioned not to place undue reliance on the forward-looking statements included in this release.